Neurology Minute
Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:04:37
- More information
Informações:
Synopsis
In part two of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the FENhance 1 and 2 trials looking at fenebrutinib in relapsing MS. For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting. Read more about the Fenebrutinib Trial.
